BeOne Medicines Ltd.
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$361.27−9.06 (-2.45%)
Close on Nov 2, 2026Market cap $41.08BP/E 64.6Yield –
BeOne Medicines Employees — Asia-Pacific (JAPAC, incl. China) by Year
BeOne Medicines Employees — Asia-Pacific (JAPAC, incl. China): 8,612 in FY2025, up 2.8% from a year earlier.
Latest, FY2025
8,612
Period ended Dec 31, 2025
Change on a year earlier
+2.8%
8,377 in FY2024
History
4 years
Since FY2022
Sources
2
Documents cited below
Where the FY2025 figure comes from
“JAPAC Number 8,215 8,377 8,612”
Source: 2025 ESG Report ↗
Reported in BeOne Responsible Business & Sustainability Report (ESG).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Employees — Asia-Pacific (JAPAC, incl. China) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 8,612 | +2.8% | 2025 ESG Report ↗ |
| FY2024 | Dec 31, 2024 | 8,377 | +2.0% | 2025 ESG Report ↗ |
| FY2023 | Dec 31, 2023 | 8,215 | +10.1% | 2025 ESG Report ↗ |
| FY2022 | Dec 31, 2022 | 7,463 | – | 2024 ESG Report ↗ |
Cite this data
StockData. (2026). BeOne Medicines Employees — Asia-Pacific (JAPAC, incl. China), annual FY2022–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/esg-emp-japac
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.